Cover Image

An adjusted ELISpot-based immunoassay for evaluation of SARS-CoV-2-specific T-cell responses

Like antibody evaluation, using an effective antigen-specific T-cell immunity assessment method in coronavirus disease 2019 (COVID-19) patients, survivors and vaccinees is crucial for understanding the immune persistence, prognosis assessment, and vaccine development for COVID-19. This study evaluat...

Full description

Saved in:

Bibliographic Details
Main Authors:	Hao Lin (Author), Jie Zhang (Author), Shaobo Dong (Author), Yaning Liu (Author), Peipei Liu (Author), George F. Gao (Author), William J. Liu (Author), Guizhen Wu (Author)
Format:	Book
Published:	Elsevier, 2022-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Seroprevalence of SARS-CoV-2 Assessed by Four Chemiluminescence Immunoassays and One Immunocromatography Test for SARS-Cov-2
by: Pellegrino Cerino, et al.
Published: (2021)

Performance evaluation of a Sars-CoV-2 rapid test and two automated immunoassays
by: Márcia J. Castejon, et al.
Published: (2021)

An online survey among convalescents 5 months post SARS-CoV-2 infection in China
by: Yalan Wang, et al.
Published: (2024)

Low performance of a SARS-CoV-2 point-of-care lateral flow immunoassay in symptomatic children during the pandemic
by: Marcelo Comerlato Scotta, et al.
Published: (2022)

Genomic characterization of SARS-CoV-2 identified in a reemerging COVID-19 outbreak in Beijing's Xinfadi market in 2020
by: Yong Zhang, et al.
Published: (2020)

Bioinformatic modelling of SARS-CoV-2 pandemic with a focus on country-specific dynamics
by: Jakub Liu, et al.
Published: (2023)

Cold-chain transportation in the frozen food industry may have caused a recurrence of COVID-19 cases in destination: Successful isolation of SARS-CoV-2 virus from the imported frozen cod package surface
by: Peipei Liu, et al.
Published: (2020)

A five-compartment model of age-specific transmissibility of SARS-CoV-2
by: Ze-Yu Zhao, et al.
Published: (2020)

Comparison of the Characteristics of Cytokine Storm and Immune Response Induced by SARS-CoV, MERS-CoV, and SARS-CoV-2 Infections
by: Liu T, et al.
Published: (2021)

Anti-SARS‐CoV‐2 Repurposing Drug Database: Clinical Pharmacology Considerations
by: Xinyuan Zhang, et al.
Published: (2021)

Omicron variant of SARS-CoV-2 imposes a new challenge for the global public health
by: Zepeng Xu, et al.
Published: (2022)

Recent advances in developing small-molecule inhibitors against SARS-CoV-2
by: Rong Xiang, et al.
Published: (2022)

Detection of Antibodies to Chlamydia trachomatis With Peptide-Based Species-Specific Enzyme Immunoassay
by: Ale Närvänen, et al.
Published: (1997)

Characterization of SARS-CoV-2 worldwide transmission based on evolutionary dynamics and specific viral mutations in the spike protein
by: Jiluo Liu, et al.
Published: (2021)

A Smartphone-Based Platform Assisted by Artificial Intelligence for Reading and Reporting Rapid Diagnostic Tests: Evaluation Study in SARS-CoV-2 Lateral Flow Immunoassays
by: David Bermejo-Peláez, et al.
Published: (2022)

Comparison of capillary blood and plasma samples for the evaluation of seroprevalence to SARS-CoV-2 antibodies by lateral flow immunoassay in a university population in Medellín, Colombia, 2020
by: Miguel Octavio Pérez Navarro, et al.
Published: (2023)

Neutralizing and enhancing antibodies against SARS-CoV-2
by: Yafei Liu, et al.
Published: (2022)

Point of care detection of SARS-CoV-2 antibodies and neutralisation capacity-lateral flow immunoassay evaluation compared to commercial assay to inform potential role in therapeutic and surveillance practices
by: Jonathan McGrath, et al.
Published: (2023)

The utility of SARS‐CoV‐2‐specific serology in COVID‐19 diagnosis
by: Tasnim Hasan, et al.
Published: (2021)

CoV-Seq, a New Tool for SARS-CoV-2 Genome Analysis and Visualization: Development and Usability Study
by: Liu, Boxiang, et al.
Published: (2020)

Children Infected With SARS-CoV-2 From Family Clusters
by: Dan Sun, et al.
Published: (2020)

The coverage of SARS-CoV-2 vaccination and the willingness to receive the SARS-CoV-2 variant vaccine among employees in China
by: Xi-Ru Zhang, et al.
Published: (2023)

Anti-SARS-CoV-2-specific antibodies in human breast milk following SARS-CoV-2 infection during pregnancy: a prospective cohort study
by: Irene Fernández-Buhigas, et al.
Published: (2024)

SARS-CoV-2: The Second Wave in Europe
by: Fokas, Athanassios S, et al.
Published: (2021)

Research progress on vaccine efficacy against SARS-CoV-2 variants of concern
by: Lianlian Bian, et al.
Published: (2022)

Activation of Tenofovir Alafenamide and Sofosbuvir in the Human Lung and Its Implications in the Development of Nucleoside/Nucleotide Prodrugs for Treating SARS-CoV-2 Pulmonary Infection
by: Jiapeng Li, et al.
Published: (2021)

Early detection of SARS-CoV-2 variants through dynamic co-mutation network surveillance
by: Qiang Huang, et al.
Published: (2023)

Product of natural evolution (SARS, MERS, and SARS-CoV-2); deadly diseases, from SARS to SARS-CoV-2
by: Mohamad Hesam Shahrajabian, et al.
Published: (2021)

Technical specifications for the environmental monitoring of SARS-CoV-2 in farmers' (trade) markets in China
Published: (2021)

Differences in case-fatality-rate of emerging SARS-CoV-2 variants
by: Jing Liu, et al.
Published: (2023)

Coronaviruses SARS-CoV, MERS-CoV, and SARS-CoV-2 helicase inhibitors: a systematic review of in vitro studies
by: Nimer Mehyar
Published: (2023)

Trends in MERS-CoV, SARS-CoV, and SARS-CoV-2 (COVID-19) Diagnosis Strategies: A Patent Review
by: José Adão Carvalho Nascimento Junior, et al.
Published: (2020)

Potent SARS-CoV-2 binding and neutralization through maturation of iconic SARS-CoV-1 antibodies
by: Romain Rouet, et al.
Published: (2021)

Development of SARS-CoV-2 specific IgG and IgA antibodies in serum and milk with different SARS-COV-2 vaccines in lactating women
by: Carolina Lechosa-Muñiz, et al.
Published: (2023)

The Disease Severity and Clinical Outcomes of the SARS-CoV-2 Variants of Concern
by: Lixin Lin, et al.
Published: (2021)

Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development
by: Xiao-Huan Liu, et al.
Published: (2022)

Advances in Immunoassay Technology
Published: (2012)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
by: Surjeet Verma, et al.
Published: (2020)

On the SARS-CoV-2 Variants
by: Fabio Scarpa, et al.
Published: (2024)

Variant-specific deleterious mutations in the SARS-CoV-2 genome reveal immune responses and potentials for prophylactic vaccine development
by: Md. Aminul Islam, et al.
Published: (2023)